The Twin Threats
Tuberculosis (TB) and HIV are two of the deadliest infectious diseases on the planet. They hit hardest in low- and middle-income countries, where resources are already stretched thin.
For decades, doctors have known these two infections are linked. But the exact size of that risk has been murky. That uncertainty makes it harder to prioritize testing and treatment where it’s needed most.
TB is a bacterial infection that usually attacks the lungs. It spreads through the air when someone coughs or sneezes. Without treatment, it can be fatal.
HIV weakens the immune system, leaving the body vulnerable to infections it would normally fight off. TB is one of the most common and dangerous opportunistic infections for people living with HIV.
Current guidelines recommend frequent TB screening for people with HIV. But in many places, testing is limited or delayed. This study aimed to pin down exactly how much higher the risk is—and what that means for public health efforts.
We used to talk about the link between TB and HIV in general terms. We knew they were “related,” but we didn’t have a clear, pooled number showing the true gap in risk.
This new analysis changes that. It combines data from 12 large surveys across nine African countries. It gives us a hard number for the difference in TB prevalence between people with and without HIV.
The result is a stark reminder of how much work remains.
How the Immune System’s “Security Guard” Gets Overwhelmed
Think of your immune system as a security team for your body. Its job is to spot intruders—like the TB bacteria—and lock them down before they cause trouble.
HIV attacks the very cells that lead this security team. As the HIV virus weakens these cells, the body’s ability to contain the TB bacteria drops.
It’s like a castle with its walls crumbling. The TB bacteria, which might have been dormant in a corner, can now break out and start a full-scale invasion. That’s why the risk of active, contagious TB skyrockets.
Researchers conducted a systematic review and meta-analysis. They looked at TB prevalence surveys published between January 1993 and October 2025.
They focused on low- and middle-income countries. The final analysis included 12 surveys from nine countries in Southern and Eastern Africa. In total, they looked at data from over 264,000 participants.
The goal was to compare the rates of bacteriologically-confirmed TB in people living with HIV versus those without.
The Numbers Behind the Risk
The findings were striking. In 11 of the 12 surveys, TB prevalence was higher in people living with HIV.
The overall pooled risk ratio was 3.86. In plain English, this means people living with HIV were nearly four times more likely to have active TB than those without HIV. The data suggests the true risk could be as high as six times greater.
This is a massive difference. It shows that HIV doesn’t just slightly increase TB risk—it multiplies it.
The Diagnosis Gap
The researchers also looked at something called the notification-to-prevalence (N:P) ratio. This compares the number of people diagnosed with TB to the actual number of people who have it.
A higher ratio means more cases are being found and treated.
For people living with HIV, the N:P ratio was 1.74. For people without HIV, it was just 0.48.
This suggests that health systems are doing a better job finding and diagnosing TB in people with HIV. But the ratios also reveal a troubling reality: for both groups, many people with TB are still going undiagnosed and untreated.
This doesn’t mean the problem is solved.
A Clearer Target for Action
Experts say this data provides a powerful tool for public health. By quantifying the risk, it makes the case for stronger screening programs in HIV clinics.
It also highlights that even with better screening for people with HIV, the overall system for finding TB cases is still failing too many people. The focus needs to be on both targeted screening and broader public health efforts.
If you are living with HIV, this study reinforces a critical message: you need to be vigilant about TB.
Talk to your doctor about regular TB screening. Don’t ignore symptoms like a persistent cough, fever, or unexplained weight loss. Early detection is key to successful treatment.
For everyone else, this is a reminder that diseases rarely act alone. Understanding these connections helps build stronger, more effective health systems.
This study is a meta-analysis, meaning it looks back at existing data to find a pattern. It doesn’t test a new drug or intervention.
The next step is to use this information to improve testing and treatment on the ground. Researchers and health officials will need to figure out how to close the diagnosis gap for both people with and without HIV.
It’s a call to action: find the missing cases, and save the lives that hang in the balance.
